Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZNTL | AMGN | VRTX | REGN | BMY |
| Company | Zentalis Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 11.60 | 310.88 | 402.77 | 958.00 | 44.16 |
| High | 12.20 | 312.73 | 407.59 | 962.10 | 44.62 |
| Low | 11.58 | 298.24 | 402.05 | 951.43 | 44.06 |
| Last | 12.09 | 298.50 | 403.26 | 953.68 | 44.06 |
| Change | +0.38 | -12.79 | +2.18 | -3.32 | +0.07 |
| % Change | +3.25% | -4.11% | +0.54% | -0.35% | +0.16% |
| Volume | 35,724 | 1,382,928 | 247,079 | 62,640 | 2,007,646 |
| 20-Day Average Volume | 694,565 | 2,614,051 | 995,052 | 504,671 | 13,931,032 |
| Previous Close | 11.71 | 311.29 | 401.08 | 957.00 | 43.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 12.49 | 273.82 | 398.36 | 910.57 | 47.12 |
| 20-Day Raw Stochastic | 32.04% | 63.87% | 70.81% | 88.95% | 10.69% |
| 20-Day Relative Strength | 45.17% | 63.21% | 48.59% | 57.57% | 30.71% |
| Weighted Alpha | -34.39 | +28.08 | +15.00 | +27.53 | -35.73 |
| Today's Opinion | 88% Sell | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 88% Sell | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 8% Buy | 8% Sell | 40% Buy | 56% Buy | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.13% since 04/29/24 | +8.63% since 04/29/24 | +1.65% since 04/29/24 | +6.73% since 04/29/24 | -0.93% since 04/29/24 |
| Low | 10.82 on 05/01/24 | 272.35 on 04/30/24 | 391.70 on 04/30/24 | 885.01 on 04/30/24 | 43.33 on 05/02/24 |
| High | 12.12 on 05/06/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 | 44.76 on 04/30/24 |
| 1-Month | |||||
| %Chg | -19.63% since 04/05/24 | +11.22% since 04/05/24 | -0.96% since 04/05/24 | +1.04% since 04/05/24 | -13.83% since 04/05/24 |
| Low | 10.39 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 15.79 on 04/09/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +4.75% since 02/06/24 | -5.01% since 02/06/24 | -3.22% since 02/06/24 | +1.57% since 02/06/24 | -10.22% since 02/06/24 |
| Low | 10.39 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 18.07 on 02/28/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -2.88% since 11/06/23 | +10.04% since 11/06/23 | +4.40% since 11/06/23 | +14.43% since 11/06/23 | -16.22% since 11/06/23 |
| Low | 9.56 on 11/08/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 18.07 on 02/28/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 831,562 | 166,968,480 | 103,662,736 | 105,042,232 | 89,172,128 |
| Shares Outstanding, K | 71,013 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -292,190,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -60,920,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 1.82 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.83 on 02/27/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 29.77 | 25.27 | 41.62 |